Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Lymphedema 2Neoplasms 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × pycnogenols × Clear all
NCT00214032 2015-10-05

Pycnogenol for the Treatment of Lymphedema

University of Wisconsin, Madison

Phase 2 Completed
2 enrolled

Lymphedema

NCT00064857 2008-04-22

Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors

National Center for Complementary and Integrative Health (NCCIH)

Phase 2 Completed
26 enrolled

Lymphedema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡